An Akin legal update says FDAs recent issuance of Warning Letters to four direct-to-consumer testing companies over the use of unauthorized at-home bl...
FDA cites Nubratori Inc. for multiple manufacturing and contamination-control deficiencies following a December inspection of the companys Torrance, C...
HHS Office of Inspector General issues new guidance clarifying when pharmaceutical manufacturers can sell prescription drugs directly to patients enro...
FDA warns Malaysias Fulijaya Manufacturing about CGMP violations in its production of finished drugs.
A Friends of Cancer Research white paper explores the emerging role of AI-enabled tumor assessment tools and the framework needed to use them in valid...
Roche says its experimental dual GLP-1/GIP receptor agonist CT-388 delivered substantial and statistically significant weight loss in a Phase 2 study ...
Reuters reports that several drug companies say they are using artificial intelligence tools to speed up some of the time-intensive work needed for cl...
A Ropes & Gray year-end review examines significant changes in FDA and Justice Department enforcement actions pertaining to regulated industries and s...